Literature DB >> 24294352

Effects and interactions of MiR-577 and TSGA10 in regulating esophageal squamous cell carcinoma.

Xiang Yuan1, Jiangtu He, Fenyong Sun, Jiang Gu.   

Abstract

Testis specific 10 (TSGA10) was originally identified as a testis-specific protein and tumor-associated antigen in a number of cancer types. In this study, we found that down-regulation of TSGA10 was associated with increased malignancy and clinical features of esophageal squamous cell carcinomas (ESCCs). Moreover, increased expression of TSGA10 inhibited, while its knockdown promoted, tumor formation in vivo in nude mice. At the 3'UTR of the TSGA10 gene we identified two binding sites for microRNA-577 (miR-577). Further investigation demonstrated that expression levels of miR-577 and TSGA10 were negatively correlated to each other in ESCC cell lines and tumor samples. Moreover, manipulation of miR-577 and TSGA10 expression confirmed that miR-577 can regulate TSGA10 and in turn affect cell proliferation in vitro. Additionally, with flow cytometry and manipulation of the mir-577/TSGA10 axis, it was found that mir-577/TSGA10 axis influenced the growth of ESCC through regulating the G1-S phase transition. We also obtained evidence to establish that mir-577/TSGA10 axis activation was always accompanied by inactivation of the p53 pathway or the Rb pathway or both, thus, the latter two pathways are obligatory for progression of ESCCs with mir-577/TSGA10 axis activation. In addition, we found that such an interactive pathway in regulating cancer cell proliferation was restricted to a few cancer types including ESCC, but not uniformly applicable to other cancer types. This newly discovered regulatory mechanism provides a new dimension for ESCC diagnosis and therapy.

Entities:  

Keywords:  ESCC; G1-S phase transition; Rb/p16 pathway; TSGA10; miR-577; p53/p21 pathway

Mesh:

Substances:

Year:  2013        PMID: 24294352      PMCID: PMC3843246     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  42 in total

1.  Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.

Authors:  Chiachen Chen; Yuan-Ching Chang; Chien-Liang Liu; King-Jen Chang; Ing-Cherng Guo
Journal:  Breast Cancer Res Treat       Date:  2006-06-03       Impact factor: 4.872

2.  Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.

Authors:  Stephanie Ma; Jessie Y J Bao; Pak Shing Kwan; Yuen Piu Chan; Carol M Tong; Li Fu; Na Zhang; Amy H Y Tong; Yan-Ru Qin; Sai Wah Tsao; Kwok Wah Chan; Si Lok; Xin-Yuan Guan
Journal:  Gastroenterology       Date:  2012-06-13       Impact factor: 22.682

3.  Over-expression of the X-linked inhibitor of apoptosis protein (XIAP) delays serum deprivation-induced apoptosis in CHO-K1 cells.

Authors:  Jane C J Liew; Wen Siang Tan; Noorjahan Banu Mohamed Alitheen; Eng-Seng Chan; Beng Ti Tey
Journal:  J Biosci Bioeng       Date:  2010-03-29       Impact factor: 2.894

4.  Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.

Authors:  K Ichimura; M B Bolin; H M Goike; E E Schmidt; A Moshref; V P Collins
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

5.  Defects in p21WAF1/CIP1, Rb, and c-myc signaling in phorbol ester-resistant cancer cells.

Authors:  M V Blagosklonny; N S Prabhu; W S El-Deiry
Journal:  Cancer Res       Date:  1997-01-15       Impact factor: 12.701

6.  Dynein light chain 1 contributes to cell cycle progression by increasing cyclin-dependent kinase 2 activity in estrogen-stimulated cells.

Authors:  Petra den Hollander; Rakesh Kumar
Journal:  Cancer Res       Date:  2006-06-01       Impact factor: 12.701

7.  Expression of calcineurin B homologous protein 2 protects serum deprivation-induced cell death by serum-independent activation of Na+/H+ exchanger.

Authors:  Tianxiang Pang; Shigeo Wakabayashi; Munekazu Shigekawa
Journal:  J Biol Chem       Date:  2002-09-10       Impact factor: 5.157

8.  Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability.

Authors:  Andrei V Budanov; Tzipora Shoshani; Alexander Faerman; Elena Zelin; Iris Kamer; Hagar Kalinski; Svetlana Gorodin; Alla Fishman; Ayelet Chajut; Paz Einat; Rami Skaliter; Andrei V Gudkov; Peter M Chumakov; Elena Feinstein
Journal:  Oncogene       Date:  2002-09-05       Impact factor: 9.867

9.  miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis.

Authors:  Christoph A Gebeshuber; Kurt Zatloukal; Javier Martinez
Journal:  EMBO Rep       Date:  2009-02-27       Impact factor: 8.807

10.  Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFbeta cell cycle arrest.

Authors:  Sharon Sheahan; Christopher O Bellamy; Donald R Dunbar; David J Harrison; Sandrine Prost
Journal:  BMC Cancer       Date:  2007-11-19       Impact factor: 4.430

View more
  16 in total

Review 1.  The role of microRNA in esophageal squamous cell carcinoma.

Authors:  Kazuto Harada; Yoshifumi Baba; Takatsugu Ishimoto; Hironobu Shigaki; Keisuke Kosumi; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  J Gastroenterol       Date:  2016-01-21       Impact factor: 7.527

2.  miR-143 inhibits migration and invasion through regulating LASP1 in human esophageal cancer.

Authors:  Huifeng Liu; Mengli Zheng; Yachao Zhao; Shuxin Zhang
Journal:  Int J Clin Exp Pathol       Date:  2019-02-01

3.  MicroRNA-577 inhibits gastric cancer growth by targeting E2F transcription factor 3.

Authors:  Zhanjiang Yu; Wei Zhang; Fengchun Deng
Journal:  Oncol Lett       Date:  2015-06-17       Impact factor: 2.967

Review 4.  MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets.

Authors:  J Huang; S-Y Zhang; Y-M Gao; Y-F Liu; Y-B Liu; Z-G Zhao; K Yang
Journal:  Cell Prolif       Date:  2014-06-06       Impact factor: 6.831

5.  MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.

Authors:  Zheng-Chao Nie; Wen-Hao Weng; Yu-Shan Shang; Yin Long; Jing Li; Yan-Ting Xu; Zhi Li
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

6.  microRNA-186 inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma by targeting SKP2.

Authors:  Wei He; Jianfang Feng; Yan Zhang; Yuanyuan Wang; Wenqiao Zang; Guoqiang Zhao
Journal:  Lab Invest       Date:  2015-11-16       Impact factor: 5.662

7.  KDM4C, a H3K9me3 Histone Demethylase, is Involved in the Maintenance of Human ESCC-Initiating Cells by Epigenetically Enhancing SOX2 Expression.

Authors:  Xiang Yuan; Jinyu Kong; Zhikun Ma; Na Li; Ruinuo Jia; Yiwen Liu; Fuyou Zhou; Qimin Zhan; Gang Liu; Shegan Gao
Journal:  Neoplasia       Date:  2016-09-19       Impact factor: 5.715

8.  How interacting pathways are regulated by miRNAs in breast cancer subtypes.

Authors:  Claudia Cava; Antonio Colaprico; Gloria Bertoli; Gianluca Bontempi; Giancarlo Mauri; Isabella Castiglioni
Journal:  BMC Bioinformatics       Date:  2016-11-08       Impact factor: 3.169

9.  Metastasis-associated miR-23a from nasopharyngeal carcinoma-derived exosomes mediates angiogenesis by repressing a novel target gene TSGA10.

Authors:  Lili Bao; Bo You; Si Shi; Ying Shan; Qicheng Zhang; Huijun Yue; Jie Zhang; Wei Zhang; Yunwei Shi; Yifei Liu; Xin Wang; Dong Liu; Yiwen You
Journal:  Oncogene       Date:  2018-03-09       Impact factor: 9.867

10.  CXCL5/NF-κB Pathway as a Therapeutic Target in Hepatocellular Carcinoma Treatment.

Authors:  Xingqing Jia; Shuangqin Wei; Wujun Xiong
Journal:  J Oncol       Date:  2021-05-31       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.